Biotimize
- CMO, CRO
- Biotech or pharma, therapeutic R&D
- Other R&D services
Biotimize is Brazil’s leading CDMO dedicated to biologics, offering end-to-end services from cell line development to GMP manufacturing and clinical trial material supply. As the first Brazilian CDMO fully focused on biologics, Biotimize acts as a strategic catalyst in the national ecosystem, fostering collaboration among companies, government agencies, and regulatory authorities such as ANVISA. Our mission is to make Brazil a key hub in the global biologics value chain, providing seamless access for companies seeking to develop, produce, or conduct clinical studies in the country. Amid global geopolitical shifts, Biotimize is the ideal partner to navigate and unlock the vast potential of the Brazilian and Latin American markets.